Csenge Advisory Group’s Asensus Surgical, Inc. ASXC Stock Holding History

Csenge Advisory Group’s Portfolio ASXC Stock Details ASXC Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q1	–	Sell	-10,000	Closed	-$29K	–	719
2021 Q4	$29K	Hold	10,000	–	–	﹤0.01%	545
2021 Q3	$18K	Hold	10,000	–	–	﹤0.01%	572
2021 Q2	$29K	Hold	10,000	–	–	﹤0.01%	548
2021 Q1	$26K	Hold	10,000	–	–	﹤0.01%	489
2020 Q4	$6K	Hold	10,000	–	–	﹤0.01%	429
2020 Q3	$4K	Buy	+10,000	New	+$3.87K	﹤0.01%	391

Other funds holding ASXC

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Osaic Holdings Scottsdale, Arizona $68.3B AUM 20.5% 1-Year Est. Return

Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return

Rafferty Asset Management New York $24.6B AUM 47.06% 1-Year Est. Return

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

Csenge Advisory Group's ASXC Position: Q1 2022 in Review

Csenge Advisory Group sold out of Asensus Surgical, Inc. (ASXC) in Q1 2022, closing a stake of 10,000 shares — an estimated $29K sold.

Csenge Advisory Group first reported a position in ASXC in Q3 2020 and held it in 6 quarters. The position peaked at $29K in Q4 2021. 115 funds tracked by Wall St. Rank hold ASXC as of Q1 2022.

Csenge Advisory Group reported no remaining Asensus Surgical, Inc. position as of Q1 2022 after selling out during the quarter.
Csenge Advisory Group sold 10,000 Asensus Surgical, Inc. shares in Q1 2022, an estimated $29K.
Csenge Advisory Group first reported a position in Asensus Surgical, Inc. in Q3 2020 and held it in 6 quarters.
Csenge Advisory Group's Asensus Surgical, Inc. position peaked at $29K in Q4 2021.
115 funds tracked by Wall St. Rank held Asensus Surgical, Inc. as of Q1 2022.

Based on Csenge Advisory Group's 13F filing for Q1 2022, filed 9 May 2022.